Dr. Wang currently serves as a Molecular and Surgical Pathologist at NeoGenomics. Dr. Wang is board-certified in Anatomic Pathology, Clinical Pathology and Molecular Genetic Pathology. She completed two fellowships in Molecular Genetic Pathology and Surgical Pathology with special interest in breast pathology and soft tissue pathology from Oregon Health and Science University. She also completed a combined Anatomic and Clinical Pathology residency at Oregon Health and Science University. Dr. Wang is a junior member of the CAP Biochemical and Molecular Genetic Committee from 2018 to 2019 and is a member of several professional organizations including USCAP, CAP, and ASCP. Dr. Wang’s publications include more than 10 peer-reviewed journal articles and several presentations in scientific journals and at national pathology meetings. She also has a chapter on the molecular testing for post hematopoietic stem cell transplant surveillance in Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care, Third Edition.